Korro Bio (KRRO) Tax Rate (2020 - 2026)
Korro Bio's (KRRO) quarterly Tax Rate came in at 0.57% in Q2 2026, down 57.0% on a YoY basis from 1.34% in Q2 2025, and down 18.05% quarter-over-quarter from 0.49% in Q1 2026.
Powered by 
Analysis
Korro Bio (KRRO) Tax Rate (2020 - 2026) Analysis & Trends
Korro Bio (KRRO) has reported Tax Rate for 7 consecutive years, with 0.57% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate fell 57.0% year-over-year to 0.57%; the trailing twelve-month figure through Jun 2026 stood at 22.7% (up 346.0% YoY), and the FY2025 full-year result was 20.79%, down 20.0% from the prior year.
- Tax Rate slipped to 0.57% in Q2 2026 per KRRO's latest filing, from 0.49% in the prior quarter.
- Across five years, Tax Rate topped out at 83.01% in Q4 2024 and bottomed at 0.57% in Q2 2026.
- Historically, Tax Rate has averaged 10.03% across 5 years, with a median of 0.01% in 2022.
- The sharpest annual moves came in 2022 and 2025: Tax Rate jumped 32 bps in 2022, then slumped 3461 bps in 2025.
- Over 5 years, Tax Rate stood at 0.31% in 2022, then slumped by 150 bps to 0.15% in 2023, then soared by 54276 bps to 83.01% in 2024, then tumbled by 42 bps to 48.4% in 2025, then tumbled by 101 bps to 0.57% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 0.57%, 0.49%, and 48.4% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.46 Bn | 192.47 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.92 Bn | 176.75 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 131.37 Bn | 123.51 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.86 Bn | 73.87 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.29 Bn | 55.10 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 53.76 Bn | 48.62 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.16 Bn | 29.85 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.90 Bn | 30.62 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.13 Bn | 29.13 Bn | 1.16 Mn | 1.34% |
| 10 | Korro Bio | 225.43 Mn | 110.39 Mn | - | -0.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.57% |
| Mar 31, 2026 | -0.49% |
| Dec 31, 2025 | 48.40% |
| Jun 30, 2025 | 0.00% |
| Dec 31, 2024 | 83.01% |
| Sep 30, 2024 | 0.04% |
| Jun 30, 2024 | -0.14% |
| Mar 31, 2024 | -0.09% |
| Jun 30, 2023 | -0.15% |
| Dec 31, 2022 | 0.31% |
| Sep 30, 2022 | 0.12% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.05% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.06% |
| Dec 31, 2020 | 0.24% |
| Sep 30, 2020 | -0.28% |
| Jun 30, 2020 | -0.12% |
| Mar 31, 2020 | -0.78% |